CTT Pharmaceutical Holdings News & Analysis

CTT Pharmaceutical CEO Ryan Khouri Buys $114 of Stock

CTT Pharmaceutical Holdings' CEO Ryan Khouri purchased company stock worth $114. The article reports a direct insider purchase, indicating personal investment by the CEO. No further details on the number of shares or timing were provided. Insider purchases can signal confidence in the company's future performance, though the small dollar amount here is limited. This move may attract investor interest in CTT Pharmaceutical Holdings due to the CEO's stake increase. For ordinary investors, this small insider purchase reflects a personal vote of confidence but does not significantly impact the company's financials or stock supply.